Ruxolitinib - Incyte Corporation/Novartis
At a glance
- Drug Originator Incyte Corporation
- Drug Licenced by CMS Medical; Maruho; Novartis
- Drug Class 2 ring heterocyclic compounds; Anti-inflammatories; Antianaemics; Antibronchitics; Antihaemorrhagics; Antineoplastics; Antipsoriatics; Antirheumatics; Antivirals; Cyclopentanes; Nitriles; Pyrazoles; Pyrimidines; Pyrroles; Skin disorder therapies; Small molecules
- Mechanism of Action Janus kinase 1 inhibitors; Janus kinase-2 inhibitors
- USA Patent Applicants INCYTE CORP
- USA Patents 32
- NDAs 2
- International Patents 321
- Patent Applications 1,028
Table of Contents

Disclaimer